Uterine leiomyomas (fibroids or myomas) are diagnosed in one-fourth of all women and up to 75 % of black women. The direct health care costs attributable to leiomyomas exceed $2.1 billion annually. However, our work and that of others, report that indirect costs (disability and absenteeism) are a large part of total costs for women with uterine fibroids. Addressing the symptoms of clinically significant uterine fibroids and controlling health care costs from a societal perspective are both important goals. Despite the prevalence and morbidity of this disease and the significant costs of treatment, there is a dearth of evidence to guide therapy. Two minimally-invasive FDA-approved techniques treat leiomyomas in a wide variety of sizes and locations: uterine artery embolization (UAE) and MRI-guided focused ultrasound surgery (MRgFUS). However, they differ significantly in approach, mechanism of action and side effects and they have never been directly compared. We therefore propose the FIRSTT trial: Fibroid Interventions: Reducing Symptoms Today and Tomorrow), a randomized clinical trial treating 220 women with symptomatic uterine leiomyomas with UAE or MRgFUS and following them for three years. A racially diverse cohort of subjects will be achieved by recruiting through Mayo Clinic Rochester and Duke University. This trial is powered to compare short- and long-term outcomes, adverse events, predictors of outcome, and costs of each treatment.
The specific aims of this project are: 1) To report comprehensive outcomes and predictors of outcome following UAE and MRgFUS. 2) To quantitate and compare the ovarian impairment following UAE and MRgFUS. 3) To produce an economic analysis of UAE and MRgFUS treatment from a U.S. societal perspective.
Uterine leiomyomas or fibroids are found in one-fourth of all women and up to three-fourths of black women. Fibroids are the leading cause of hysterectomy and account for health care costs over $2.1 billion annually. This study proposes to study the outcomes and limitations of two widely used alternatives to hysterectomy for fibroids: uterine artery embolization (UAE) and magnetic resonance imaging guided focused ultrasound surgery (MRgFUS).
|Eltoukhi, Heba M; Modi, Monica N; Weston, Meredith et al. (2014) The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol 210:194-9|
|Cain-Nielsen, Anne H; Moriarty, James P; Stewart, Elizabeth A et al. (2014) Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA. J Comp Eff Res 3:503-14|
|Puri, Kanchan; Famuyide, Abimbola O; Erwin, Patricia J et al. (2014) Submucosal fibroids and the relation to heavy menstrual bleeding and anemia. Am J Obstet Gynecol 210:38.e1-7|
|Hodge, Jennelle C; Pearce, Kathryn E; Clayton, Amy C et al. (2014) Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. Am J Obstet Gynecol 210:572.e1-7|
|Hodge, Jennelle C; Kim, Tae-Min; Dreyfuss, Jonathan M et al. (2012) Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity. Hum Mol Genet 21:2312-29|
|Stewart, Elizabeth A (2012) Uterine fibroids and evidence-based medicine--not an oxymoron. N Engl J Med 366:471-3|
|Rocca, Walter A; Grossardt, Brandon R; Shuster, Lynne T et al. (2012) Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis 10:175-8|
|Stewart, Elizabeth A; Taran, F Andrei; Chen, Jun et al. (2011) Magnetic resonance elastography of uterine leiomyomas: a feasibility study. Fertil Steril 95:281-4|
|Laughlin, Shannon K; Stewart, Elizabeth A (2011) Uterine leiomyomas: individualizing the approach to a heterogeneous condition. Obstet Gynecol 117:396-403|
|Wechter, Mary Ellen; Stewart, Elizabeth A; Myers, Evan R et al. (2011) Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends. Am J Obstet Gynecol 205:492.e1-5|
Showing the most recent 10 out of 11 publications